|
ES2815099T3
(es)
|
2013-08-05 |
2021-03-29 |
Twist Bioscience Corp |
Genotecas sintetizadas de novo
|
|
WO2021173560A1
(en)
|
2020-02-24 |
2021-09-02 |
Immatics US, Inc. |
Methods for expanding t cells for the treatment of cancer and related malignancies
|
|
CA2975852A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
WO2016172377A1
(en)
|
2015-04-21 |
2016-10-27 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
EP3350314A4
(en)
|
2015-09-18 |
2019-02-06 |
Twist Bioscience Corporation |
OLIGONUCLEIC ACID VARIANT LIBRARIES VARIANT AND SYNTHESIS THEREOF
|
|
KR102794025B1
(ko)
|
2015-09-22 |
2025-04-09 |
트위스트 바이오사이언스 코포레이션 |
핵산 합성을 위한 가요성 기판
|
|
CN108603307A
(zh)
|
2015-12-01 |
2018-09-28 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
|
FI3430030T3
(fi)
|
2016-03-16 |
2024-01-16 |
Immatics Biotechnologies Gmbh |
Transfektoituja t-soluja ja t-solureseptoreita käytettäviksi syöpien immunoterapiassa
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
CN109996876A
(zh)
|
2016-08-22 |
2019-07-09 |
特韦斯特生物科学公司 |
从头合成的核酸文库
|
|
JP6871364B2
(ja)
|
2016-09-21 |
2021-05-12 |
ツイスト バイオサイエンス コーポレーション |
核酸に基づくデータ保存
|
|
DK3551221T3
(da)
|
2016-12-08 |
2022-01-24 |
Immatics Biotechnologies Gmbh |
Hidtil ukendte t-cellereceptorer og immunterapi med anvendelse deraf
|
|
DE102016123847B3
(de)
*
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
EA201991262A1
(ru)
|
2016-12-16 |
2020-04-07 |
Твист Байосайенс Корпорейшн |
Библиотеки вариантов иммунологического синапса и их синтез
|
|
CN110892485B
(zh)
|
2017-02-22 |
2024-03-22 |
特韦斯特生物科学公司 |
基于核酸的数据存储
|
|
US10894959B2
(en)
|
2017-03-15 |
2021-01-19 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
KR20240162609A
(ko)
*
|
2017-04-10 |
2024-11-15 |
이매틱스 바이오테크놀로지스 게엠베하 |
암에 대한 면역요법에 사용하기 위한 펩티드 및 그 조합
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
AU2018284227B2
(en)
|
2017-06-12 |
2024-05-02 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
JP2020536504A
(ja)
|
2017-09-11 |
2020-12-17 |
ツイスト バイオサイエンス コーポレーション |
Ｇｐｃｒ結合タンパク質およびその合成
|
|
WO2019071164A1
(en)
*
|
2017-10-06 |
2019-04-11 |
The University Of Chicago |
SCREENING OF LYMPHOCYTES T FOR ANTIGENS SPECIFIC TO CANCER
|
|
CN111433222B
(zh)
*
|
2017-10-12 |
2025-01-28 |
得克萨斯大学体系董事会 |
用于免疫疗法的t细胞受体
|
|
CN111565834B
(zh)
|
2017-10-20 |
2022-08-26 |
特韦斯特生物科学公司 |
用于多核苷酸合成的加热的纳米孔
|
|
KR102804057B1
(ko)
|
2018-01-04 |
2025-05-07 |
트위스트 바이오사이언스 코포레이션 |
Dna 기반 디지털 정보 저장
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
EP3814497A4
(en)
|
2018-05-18 |
2022-03-02 |
Twist Bioscience Corporation |
POLYNUCLEOTIDES, REAGENTS AND METHODS FOR NUCLEIC ACID HYBRIDIZATION
|
|
JP7558151B2
(ja)
*
|
2018-09-05 |
2024-09-30 |
アダプティミューン・リミテッド |
Ｔ細胞改変
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
JP7528058B2
(ja)
*
|
2018-09-14 |
2024-08-05 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Ｔｃｒリガンドの高スループットペプチド－ｍｈｃ親和性スクリーニングのための方法
|
|
CA3124980A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
CA3131689A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for glp1 receptor
|
|
AU2020227802A1
(en)
|
2019-02-26 |
2021-10-14 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
US20200297768A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
JP7723887B2
(ja)
*
|
2019-05-08 |
2025-08-15 |
メディジーン イミュノテラピーズ ゲーエムベーハー |
操作されたｔ細胞
|
|
PH12021552979A1
(en)
|
2019-05-27 |
2023-10-09 |
Immatics Us Inc |
Viral vectors and their use in adoptive cellular therapy
|
|
EP3986938A4
(en)
*
|
2019-06-18 |
2023-06-28 |
Regeneron Pharmaceuticals, Inc. |
Mage-a4 t cell receptors and methods of use thereof
|
|
WO2020257553A1
(en)
*
|
2019-06-20 |
2020-12-24 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
WO2020257612A1
(en)
|
2019-06-21 |
2020-12-24 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
BR112022001702A2
(pt)
*
|
2019-07-30 |
2022-06-21 |
Univ Health Network |
Moléculas mhc classe ii e métodos de uso das mesmas
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
DE102019121007A1
(de)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
EP4034564A4
(en)
|
2019-09-23 |
2023-12-13 |
Twist Bioscience Corporation |
VARIANT NUCLEIC ACID LIBRARIES FOR SINGLE-DOMAIN ANTIBODIES
|
|
EP4034566A4
(en)
|
2019-09-23 |
2024-01-24 |
Twist Bioscience Corporation |
VARIANT NUCLEIC ACID BANKS FOR CRTH2
|
|
CN115279389A
(zh)
*
|
2020-01-06 |
2022-11-01 |
纪念斯隆-凯特琳癌症中心 |
新型显性负性Fas多肽、包含其的细胞及其用途
|
|
DE102020111571A1
(de)
*
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
WO2022040631A1
(en)
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
CN116457371A
(zh)
*
|
2020-10-07 |
2023-07-18 |
多安生物治疗有限公司 |
T细胞受体、包含t细胞受体的免疫细胞及其使用方法
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
MX2023007817A
(es)
|
2020-12-31 |
2023-09-13 |
Immatics Us Inc |
Polipéptidos de cd8, composiciones y métodos de uso de estos.
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
WO2022225836A1
(en)
*
|
2021-04-21 |
2022-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
MX2023012899A
(es)
|
2021-05-05 |
2023-11-08 |
Immatics Biotechnologies Gmbh |
Polipeptidos de union a antigeno bma031 mejorados.
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
WO2023044488A1
(en)
|
2021-09-20 |
2023-03-23 |
Immatics US, Inc. |
Monocyte depletion of t cells populations for t-cell therapy
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
KR20240091226A
(ko)
*
|
2021-11-03 |
2024-06-21 |
큐론 바이오파마슈티칼 (상하이) 컴퍼니, 리미티드 |
신규 항 l1cam 항체
|
|
US20230142468A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
US20230192886A1
(en)
|
2021-11-08 |
2023-06-22 |
Immatics Biotechnologies Gmbh |
Adoptive cell therapy combination treatment and compositions thereof
|
|
WO2023137471A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
CA3247927A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics, Inc. |
Compositions, systems and methods for programming T-lymphocyte phenotypes by targeted gene repression
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
EP4514829A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
JP2025515603A
(ja)
|
2022-04-28 |
2025-05-20 |
イマティクス ユーエス，アイエヌシー． |
Ｉｌ－１２ポリペプチド、ｉｌ－１５ポリペプチド、ｉｌ－１８ポリペプチド、ｃｄ８ポリペプチド、それらの組成物、およびそれらの使用方法
|
|
WO2023212691A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
DOMINANT NEGATIVE TGFβ RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF
|
|
US20230355678A1
(en)
|
2022-05-05 |
2023-11-09 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
CA3260344A1
(en)
*
|
2022-06-24 |
2023-12-28 |
Amgen Inc. |
MAGEA4-SPECIFIC T-LYMPHOCYTE RECEPTORS
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
EP4590821A2
(en)
|
2022-09-19 |
2025-07-30 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for modulating t cell function
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
WO2025029835A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating il-2 gene expression
|
|
WO2025096649A1
(en)
|
2023-11-01 |
2025-05-08 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233420A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use of anti-cancer molecules
|